Bovine Blood Plasma Derivatives Market Revenue to Attain USD 2.75 Bn by 2033

24 Jul 2025

Share :

Table of Content

1. Bovine Blood Plasma Derivatives Market Revenue and Trends 2025 to 2033 2. What are the Major Factors Driving the Growth of the Bovine Blood Plasma Derivatives Market? 3. Segment Insights 4. Regional Insights 5. Bovine Blood Plasma Derivatives Market Coverage 6. Bovine Blood Plasma Derivatives Market Key Players

Bovine Blood Plasma Derivatives Market Revenue and Trends 2025 to 2033

The global bovine blood plasma derivatives market revenue surpassed USD 1.36 billion in 2025 and is predicted to attain around USD 2.75 billion by 2033, growing at a CAGR of 9.15%. The growth of the market is driven by the surging demand for animal blood products in pharmaceuticals and regenerative medicine. The rising demand for animal feed and pet nutrition and ongoing technological advances that are lowering costs and enhancing product purity are boosting the growth of the market.

What are the Major Factors Driving the Growth of the Bovine Blood Plasma Derivatives Market?

The market for bovine blood plasma derivatives is expanding at a rapid pace due to the increasing demand for plasma derivatives from the pharmaceutical and biotechnology industries. Plasma derivatives are widely used as specialty proteins, in the development of pharmaceuticals, vaccine formulations, drug delivery systems, and wound healing. These derivatives are rich in proteins such as immunoglobulins and albumin. The continuing global increase in the consumption of meat products further boosts the growth of the market.

The rising demand for animal nutrition, along with useful immunity-boosting plasma components that would enhance animal health and performance, create immense opportunities in the market. Advances in plasma fractionation and purification technologies are enhancing the quality and safety of these derivatives and expanding their scope of applications. Moreover, supportive regulatory environment or new products and rising R&D activities open up new growth avenues.

Segment Insights

• By derivative type, the fetal bovine serum (FBS) segment accounted for the largest share of the market in 2024. This is because of its unique cell-growth enhancing characteristics, which are crucial in biopharmaceutical research, cell culture, and vaccine production.
• By application, the pharmaceuticals segment led the market while holding the largest revenue share in 2024. This is mainly due to the widespread application of bovine blood plasma in developing vaccines, therapeutic proteins, and advanced drug delivery systems.
• By end-user, the hospitals & clinics segment held the largest share of the bovine blood plasma derivatives market in 2024, driven by their crucial role in administering therapeutic proteins and immunoglobulins. These settings often have advanced infrastructure, including sophisticated drug delivery systems, making them the primary end-users of bovine blood plasma derivatives.

Regional Insights

North America dominated the bovine blood plasma derivatives market while capturing a major share in 2024. This is primarily due to its well-established healthcare infrastructure, high volumes of surgical procedures, and well-established biotech industry, which is investing heavily in plasma fractionation and the development of therapeutic proteins. Rising research into cell-based therapies further supports market growth.

Asia Pacific is the fastest-growing market due to the increasing demand for biopharmaceutical products. The rising demand for cell-based therapies and increasing healthcare spending further contribute to regional market growth.

Bovine Blood Plasma Derivatives Market Coverage

Recent Development

• In August 2023, California-based cultivated meat company Omeat has revealed an alternative to fetal bovine serum (FBS) made with the bovine plasma of healthy cows. FBS is an ethically controversial and expensive cell nutrient media used by multiple industries.
  (Source: https://www.isaaa.org)

Bovine Blood Plasma Derivatives Market Key Players

• Thermo Fisher Scientific
• Merck KGaA (SigmaAldrich)
• GE Healthcare / Cytiva
• LAMPIRE Biological Laboratories
• Proliant Biologicals
• Tissue Culture Biologicals
• Bovogen Biologicals
• Rocky Mountain Biologicals
• SeraCare (MP Biomedical)
• Kraeber & Co GmbH
• Auckland BioSciences Ltd.
• Atlanta Biologicals, Inc.
• Biowest (France)
• Lake Immunogenics, Inc.
• ExCell Bio
• Zhejiang Tianhang Biotechnology
• American Protein Company
• Serana, among others.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6447

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.co |+1 804 441 9344